Reuter-Rice Karin, Eads Julia K, Berndt Suzanna Boyce, Bennett Ellen
Annu Rev Nurs Res. 2015;33(1):185-217. doi: 10.1891/0739-6686.33.185.
Our objective is to review the most widely used biomarkers and gene studies reported in pediatric traumatic brain injury (TBI) literature, to describe their findings, and to discuss the discoveries and gaps that advance the understanding of brain injury and its associated outcomes. Ultimately, we aim to inform the science for future research priorities.
We searched PubMed, MEDLINE, CINAHL, and the Cochrane Database of Systematic Reviews for published English language studies conducted in the last 10 years to identify reviews and completed studies of biomarkers and gene associations in pediatric TBI. Of the 131 biomarker articles, only 16 were specific to pediatric TBI patients, whereas of the gene association studies in children with TBI, only four were included in this review.
Biomarker and gene attributes are grossly understudied in pediatric TBI in comparison to adults. Although recent advances recognize the importance of biomarkers in the study of brain injury, the limited number of studies and genomic associations in the injured brain has shown the need for common data elements, larger sample sizes, heterogeneity, and common collection methods that allow for greater understanding of the injured pediatric brain. By building on to the consortium of interprofessional scientists, continued research priorities would lead to improved outcome prediction and treatment strategies for children who experience a TBI.
Understanding recent advances in biomarker and genomic studies in pediatric TBI is important because these advances may guide future research, collaborations, and interventions. It is also important to ensure that nursing is a part of this evolving science to promote improved outcomes in children with TBIs.
我们的目的是回顾儿科创伤性脑损伤(TBI)文献中报道的最广泛使用的生物标志物和基因研究,描述其研究结果,并讨论有助于增进对脑损伤及其相关后果理解的发现和差距。最终,我们旨在为未来的研究重点提供科学依据。
我们在PubMed、MEDLINE、CINAHL和Cochrane系统评价数据库中搜索了过去10年发表的英文研究,以确定儿科TBI中生物标志物和基因关联的综述及完整研究。在131篇生物标志物文章中,只有16篇专门针对儿科TBI患者,而在TBI儿童的基因关联研究中,本综述仅纳入了4篇。
与成人相比,儿科TBI中生物标志物和基因特性的研究严重不足。尽管最近的进展认识到生物标志物在脑损伤研究中的重要性,但受伤大脑中研究和基因组关联数量有限,这表明需要通用数据元素、更大样本量、异质性以及通用收集方法,以便更好地了解受伤的儿科大脑。通过建立跨专业科学家联盟,持续的研究重点将有助于改善TBI儿童的预后预测和治疗策略。
了解儿科TBI生物标志物和基因组研究的最新进展很重要,因为这些进展可能指导未来的研究、合作和干预。确保护理成为这一不断发展的科学的一部分,以促进TBI儿童改善预后也很重要。